We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Emcor
EME
$36.8B
| $2.73M | 0.01% |
23,688
-13,624
| -37% | -$1.56M |
|
452
Henry Schein
HSIC
$10.1B
| $2.71M | 0.01% |
41,153
+7,072
| +21% | +$525K |
|
453
Netflix
NFLX
$309B
| $2.68M | 0.01% |
113,760
-408,550
| -78% | -$9.07M |
|
454
Pilgrim's Pride
PPC
$6.4B
| $2.68M | 0.01% |
+116,261
| New | +$3.36M |
|
455
Essex Property Trust
ESS
$18.1B
| $2.67M | 0.01% |
11,040
+255
| +2% | +$69K |
|
456
Cavco Industries
CVCO
$4.6B
| $2.62M | 0.01% |
12,714
+694
| +6% | +$164K |
|
|
VVNT
457
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $2.6M | 0.01% |
394,485
-24,900
| -6% | -$140K |
|
458
Globus Medical
GMED
$11.5B
| $2.58M | 0.01% |
43,382
-2,100
| -5% | -$126K |
|
459
Heartland Express
HTLD
$950M
| $2.53M | 0.01% |
176,935
+155,995
| +745% | +$2.34M |
|
460
Qfin Holdings
QFIN
$1.53B
| $2.5M | 0.01% |
194,988
-23,952
| -11% | -$349K |
|
|
SEI
461
Solaris Energy Infrastructure
SEI
$4.07B
| $2.47M | 0.01% |
264,208
+39,920
| +18% | +$411K |
|
462
KE Holdings
BEKE
$19.2B
| $2.46M | 0.01% |
140,636
+102,999
| +274% | +$1.67M |
|
463
MaxLinear
MXL
$6.74B
| $2.45M | 0.01% |
75,239
-3,200
| -4% | -$118K |
|
464
Alector
ALEC
$240M
| $2.42M | 0.01% |
256,094
+229,951
| +880% | +$2.49M |
|
465
Matsons
MATX
$6.41B
| $2.41M | 0.01% |
39,205
-19,988
| -34% | -$1.54M |
|
466
Intercontinental Exchange
ICE
$85B
| $2.41M | 0.01% |
26,642
-2,884
| -10% | -$289K |
|
467
Clorox
CLX
$12.8B
| $2.38M | 0.01% |
18,578
| – | – |
|
468
UMB Financial
UMBF
$11.4B
| $2.37M | 0.01% |
28,127
+23,044
| +453% | +$2.09M |
|
469
Fortinet
FTNT
$118B
| $2.37M | 0.01% |
48,148
+6,093
| +14% | +$330K |
|
470
NNN REIT
NNN
$8.79B
| $2.36M | 0.01% |
59,128
-20,105
| -25% | -$907K |
|
471
Allegro MicroSystems
ALGM
$7.92B
| $2.34M | 0.01% |
106,923
-500
| -0.5% | -$11.6K |
|
472
Oxford Industries
OXM
$538M
| $2.3M | 0.01% |
25,666
+11,509
| +81% | +$1.11M |
|
|
WIRE
473
DELISTED
Encore Wire Corp
WIRE
| $2.3M | 0.01% |
19,889
-9,408
| -32% | -$1.14M |
|
474
West Pharmaceutical
WST
$24.8B
| $2.29M | 0.01% |
9,327
-3,698
| -28% | -$1.13M |
|
|
Y
475
DELISTED
Alleghany Corp
Y
| $2.27M | 0.01% |
2,702
| – | – |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.